Tsugaric acid ACAS# 174391-64-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 174391-64-1 | SDF | Download SDF |
PubChem ID | 44422321 | Appearance | Powder |
Formula | C32H50O4 | M.Wt | 498.8 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2R)-2-[(3S,5R,10S,13R,14R,17R)-3-acetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid | ||
SMILES | CC(=CCCC(C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)OC(=O)C)C)C)C)C(=O)O)C | ||
Standard InChIKey | FIWGZIBLJWZUEA-NFOHWCJDSA-N | ||
Standard InChI | InChI=1S/C32H50O4/c1-20(2)10-9-11-22(28(34)35)23-14-18-32(8)25-12-13-26-29(4,5)27(36-21(3)33)16-17-30(26,6)24(25)15-19-31(23,32)7/h10,22-23,26-27H,9,11-19H2,1-8H3,(H,34,35)/t22-,23-,26+,27+,30-,31-,32+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Tsugaric acid A can significantly inhibit superoxide anion formation in fMLP/CB-stimulated rat neutrophils, it is also able to protect human keratinocytes against damage induced by ultraviolet B (UV B) light, indicates that tsugaric acid A can protect keratinocytes from photodamage. |
Targets | NO | IFN-γ |
Tsugaric acid A Dilution Calculator
Tsugaric acid A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.0048 mL | 10.0241 mL | 20.0481 mL | 40.0962 mL | 50.1203 mL |
5 mM | 0.401 mL | 2.0048 mL | 4.0096 mL | 8.0192 mL | 10.0241 mL |
10 mM | 0.2005 mL | 1.0024 mL | 2.0048 mL | 4.0096 mL | 5.012 mL |
50 mM | 0.0401 mL | 0.2005 mL | 0.401 mL | 0.8019 mL | 1.0024 mL |
100 mM | 0.02 mL | 0.1002 mL | 0.2005 mL | 0.401 mL | 0.5012 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Picropodophyllotoxin
Catalog No.:BCN2585
CAS No.:17434-18-3
- Astragaloside
Catalog No.:BCN5959
CAS No.:17429-69-5
- Caohuoside E
Catalog No.:BCN8198
CAS No.:174286-23-8
- Epimedin K
Catalog No.:BCN8201
CAS No.:174286-13-6
- Apigenin 7-O-(2G-rhamnosyl)gentiobioside
Catalog No.:BCN1524
CAS No.:174284-20-9
- Pancixanthone A
Catalog No.:BCN7379
CAS No.:174232-30-5
- Methyl 3-(2,4-dihydroxyphenyl)propionate
Catalog No.:BCN1525
CAS No.:17422-90-1
- 3-Chloro-4-hydroxypiperidin-2-one
Catalog No.:BCN3992
CAS No.:174204-83-2
- Aristolochic acid D
Catalog No.:BCN2902
CAS No.:17413-38-6
- 3-(4-Pyridyl)-D-Alanine.2HCl
Catalog No.:BCC2650
CAS No.:174096-41-4
- Tomatine
Catalog No.:BCN2966
CAS No.:17406-45-0
- Bevirimat
Catalog No.:BCC5312
CAS No.:174022-42-5
- Riluzole
Catalog No.:BCC3849
CAS No.:1744-22-5
- Amiloride HCl dihydrate
Catalog No.:BCC5068
CAS No.:17440-83-4
- Sanggenol A
Catalog No.:BCN3602
CAS No.:174423-30-4
- Tipranavir
Catalog No.:BCC2002
CAS No.:174484-41-4
- alpha-Spinasterol glucoside
Catalog No.:BCN1120
CAS No.:1745-36-4
- 2-Allylphenol
Catalog No.:BCC8518
CAS No.:1745-81-9
- SDZ 220-581
Catalog No.:BCC1939
CAS No.:174575-17-8
- SDZ 220-040
Catalog No.:BCC6992
CAS No.:174575-40-7
- SB 218795
Catalog No.:BCC7037
CAS No.:174635-53-1
- SB-222200
Catalog No.:BCC1926
CAS No.:174635-69-9
- Talnetant
Catalog No.:BCC1981
CAS No.:174636-32-9
- Phalloidin
Catalog No.:BCC7945
CAS No.:17466-45-4
Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae.[Pubmed:17655889]
Phytochemistry. 2008 Jan;69(1):234-9.
The antiinflammatory properties of triterpenoids and steroids from both Ganoderma lucidum and Ganoderma tsugae were studied. Twelve compounds, including ergosta-7,22-dien-3beta-ol (1), ergosta-7,22-dien-3beta-yl palmitate (2), ergosta-7,22-dien-3-one (3), ergosta-7,22-dien-2beta,3alpha,9alpha-triol (4), 5alpha,8alpha-epidioxyergosta-6,22-dien-3beta-ol (5), ganoderal A (6), ganoderal B (7), ganoderic aldehyde A (8), Tsugaric acid A (9), 3-oxo-5alpha-lanosta-8,24-dien-21-oic acid (10), 3alpha-acetoxy-5alpha-lanosta-8,24-dien-21-oic acid ester beta-d-glucoside (11), and tsugaric acid B (12), were assessed in vitro by determining their inhibitory effects on the chemical mediators released from mast cells, neutrophils, and macrophages. Compound 10 showed a significant inhibitory effect on the release of beta-glucuronidase from rat neutrophils stimulated with formyl-Met-Leu-Phe (fMLP)/cytochalasin B (CB) whereas compound 9 significantly inhibited superoxide anion formation in fMLP/CB-stimulated rat neutrophils. Compound 10 also exhibited a potent inhibitory effect on NO production in lipopolysaccharide (LPS)/interferon-gamma (IFN-gamma)-stimulated N9 microglial cells. Moreover, compound 9 was also able to protect human keratinocytes against damage induced by ultraviolet B (UV B) light, which indicated 9 could protect keratinocytes from photodamage.